Conflicting information about DEA registration has left many Oklahoma medical marijuana businesses uncertain about their obligations. The key distinction is that federal registration follows the activities a business actually performs, not merely the classification of its state medical marijuana license. Depending on its activities, a business may need more than one DEA registration type.
1. Bulk Manufacturer — Growers and Extractors
What it covers: Cultivating, growing, harvesting, extracting, synthesizing, and producing marijuana or marijuana-derived substances in bulk. This includes marijuana flower, bulk cannabis extracts, oils, and concentrates intended for further processing or sale.
Who they can sell to: Expressly authorized recipients under 21 C.F.R. § 1301.13(k)(1): Registered manufacturers and distributors. Whether the general coincident-distribution authority also permits direct transfers to dispensaries remains subject to interpretation.
Packaging and labeling: May package and label marijuana and marijuana products within the scope of their DEA registration and state license.
Direct sales to dispensaries: Whether marijuana manufacturers must obtain separate distributor registration to sell directly to dispensaries remains subject to differing interpretations. Although 21 C.F.R. § 1301.13(e)(1) generally permits manufacturers to distribute controlled substances as a coincident activity, the marijuana-specific provisions under § 1301.13(k)(1) expressly authorize manufacturers to transfer products to registered manufacturers and distributors, while assigning transfers to dispensaries to distributors.
Our interpretation is that separate distributor registration is the more conservative compliance approach. However, the interaction between these provisions has not been definitively resolved through published DEA guidance, and businesses should evaluate their registration obligations based on their specific operations. Applicants should keep in mind that Informal advice from a single field agent isn’t a DEA interpretation. Binding positions come from the regulation, Federal Register guidance, or written statements from Diversion Control headquarters.
Legal authority: 21 C.F.R. § 1301.13(k)(1)(i), (ii), (v); 21 U.S.C. § 802(15), (22).
2. Manufacturer — Finished-Dosage Products
What it covers: Processing marijuana or bulk extracts into finished marijuana products, including prepack, edibles, vape cartridges, tinctures, pre-rolls, capsules, and other formulated products.
Who they can sell to: Expressly authorized recipients under 21 C.F.R. § 1301.13(k)(1): Registered manufacturers and distributors. Whether the general coincident-distribution authority also permits direct transfers to dispensaries remains subject to interpretation.
Packaging and labeling: May package and label finished marijuana products within the scope of their DEA registration and state license.
Direct sales to dispensaries: Again, whether marijuana manufacturers must obtain separate distributor registration to sell directly to dispensaries remains subject to differing interpretations. Although 21 C.F.R. § 1301.13(e)(1) generally permits manufacturers to distribute controlled substances as a coincident activity, the marijuana-specific provisions under § 1301.13(k)(1) expressly authorize manufacturers to transfer products to registered manufacturers and distributors, while assigning transfers to dispensaries to distributors.
Our interpretation is that separate distributor registration is the more conservative compliance approach.However, the interaction between these provisions has not been definitively resolved through published DEA guidance, and businesses should evaluate their registration obligations based on their specific operations.
Legal authority: 21 C.F.R. § 1301.13(k)(1)(i), (ii), (v); 21 U.S.C. § 802(15).
3. Distributor — Wholesale Sales and Transfers
What it covers: Receiving marijuana and marijuana products from registered manufacturers and transferring those products to registered distributors or dispensaries (dispensers). Distribution includes wholesale transfers of marijuana products and is not limited to physically transporting products.
Who they can buy from: Registered marijuana manufacturers, including bulk manufacturers and finished-dosage manufacturers, and other distributors.
Who they can sell to: Registered distributors and dispensaries.
Packaging and labeling: Distributor registration does not independently authorize manufacturing, processing, repackaging, or relabeling marijuana products. Those activities must be separately authorized where required.
Who needs this registration: Businesses engaged in wholesale distribution, including growers and processors that sell their own marijuana products directly to dispensaries. A manufacturer may hold both manufacturer and distributor registrations.
Legal authority: 21 C.F.R. § 1301.13(k)(1)(ii), (v).
4. Dispenser — Medical Marijuana Dispensaries
What it covers: Dispensing marijuana and marijuana products to individuals authorized under state law to possess marijuana for medical purposes.
Who they can buy from: Registered marijuana distributors.
Who they can sell to: Individuals authorized under state law to possess marijuana and marijuana products for medical purposes.
Packaging and labeling: May conduct packaging and labeling activities authorized for dispensing, subject to applicable federal requirements and the limitations of the state license. Dispenser registration does not independently authorize commercial marijuana manufacturing or wholesale distribution.
Legal authority: 21 C.F.R. § 1301.13(k)(1)(iii).
Important: Manufacturer Registration Does Not Replace Distributor Registration
Under 21 C.F.R. § 1301.13(k)(1)(i), marijuana manufacturers, including growers, extractors, and finished-product processors, are expressly authorized to transfer marijuana to registered manufacturers or distributors. Section 1301.13(k)(1)(ii) expressly authorizes distributors to transfer marijuana to dispensaries.
However, § 1301.13(e)(1) generally permits manufacturers to distribute controlled substances as a coincident activity without obtaining separate distributor registration. The marijuana-specific provisions do not expressly address whether that general authority continues to apply to direct manufacturer-to-dispensary transfers. Our interpretation is that separate distributor registration is the more conservative compliance approach for manufacturers selling directly to dispensaries. However, the interaction between these provisions remains subject to differing interpretations and has not been definitively resolved through published DEA guidance.
Importantly, § 1301.13(k)(1)(v) permits a single business to hold multiple registration types. A separate LLC is not required solely to obtain both manufacturer and distributor registration.
Frequently Asked Questions: DEA Registration for Oklahoma Medical Marijuana Businesses
-
Yes. Your OMMA license remains essential to your federal authorization. Under 21 C.F.R. § 1301.13(k)(2), it constitutes conclusive evidence of state authorization, but it does not replace DEA registration. Your DEA registration cannot exceed the scope of your OMMA license. Under § 1301.13(k)(3), if your state medical marijuana license expires, is suspended, or is revoked, your DEA registration is automatically suspended as well.
-
Qualifying timely applicants may continue their authorized activities while DEA processes their submissions. Under 21 C.F.R. § 1301.13(k)(7), qualifying businesses do not need to wait for final DEA approval to rely on the pending-application provision.
As of November 5, 2026, to our knowledge, no Oklahoma business has received an approved registration under the new framework. Businesses should retain their submission confirmations, Document Control Numbers (DCNs), and state licenses.
As of November 5, 2026, to our knowledge, no Oklahoma business has received an approved registration under the new framework. Businesses should retain their submission confirmations, Document Control Numbers (DCNs), and state licenses.
-
Businesses that submitted a complete DEA application, including the required fee where applicable, between April 28 and June 26, 2026, may qualify as timely applicants under 21 C.F.R. § 1301.13(k)(7).
Qualifying timely applicants may continue their state-authorized medical marijuana activities while DEA processes their applications, including transactions with other timely applicants and DEA registrants. This authority does not extend to businesses that failed to timely apply, withdrew their applications, received a final denial, or lack the required state license.
Importantly, DEA expects timely applicants to establish compliant supply chains by November 29, 2026. Businesses should verify their trading partners' DEA registration or timely-applicant status and retain supporting documentation.
-
A Document Control Number (DCN) identifies a DEA application or submission. It is not an approved DEA registration number.
All qualifying timely applicants – including growers, processors, distributors, and dispensaries – should have a DCN associated with their Timely Applicant submission. Manufacturers and distributors receive application confirmations, while dispensaries receive confirmations of their marijuana dispenser information submissions.
A DCN helps identify and verify a business's timely submission and may be used in place of a DEA registration number for certain recordkeeping purposes under the pending-application framework. Importantly, a DCN alone does not establish authorization to operate. The business must also qualify under the applicable timely-applicant provisions and maintain its required state licenses.
-
For direct sales to dispensaries, our interpretation of the marijuana-specific regulation is likely, yes. This applies to both bulk and finished-product manufacturers.
Under 21 C.F.R. § 1301.13(k)(1), manufacturers are expressly authorized to transfer marijuana to manufacturers or distributors, while distributors are expressly authorized to transfer marijuana to dispensaries. A grower or processor selling directly to dispensaries should therefore obtain distributor registration in addition to manufacturer registration.
Businesses that applied only for manufacturer registration during the April 28–June 26, 2026 filing window should not assume that a new distributor application will qualify for the same timely-applicant protections. Businesses should consult counsel or seek clarification from DEA Diversion Control before relying on pending-application authority for additional activities.
-
No. Distribution involves transferring marijuana through the wholesale supply chain; transportation involves physically moving it. OMMA-licensed transporters need a distribution registration.
-
Yes. Under 21 C.F.R. § 1301.13(k)(1)(v), a single entity may hold multiple registration types. A grower or processor may hold both manufacturer and distributor registrations without automatically needing a separate LLC.
-
Yes. Dispensaries are included in the federal marijuana registration framework. Their submission process differs from that of manufacturers and distributors, and qualifying timely submissions may permit continued operations while DEA processes them.
-
Check the DEA's public timely-applicant list.
Appearing on the list does not mean DEA has approved the registration. Businesses should also verify the applicable state license and the activities covered by the submission.
-
Yes, if you qualify as a timely dispenser or distributor applicant. DEA's October 30, 2026 guidance permits qualifying timely dispensers and distributors to continue possessing, dispensing, and distributing existing medical marijuana inventory acquired before the guidance was issued, including inventory obtained from businesses that are not timely applicants or DEA registrants.
This exception does not authorize new purchases from unauthorized suppliers. DEA expects timely applicants to verify their trading partners and establish compliant supply chains by November 29, 2026. That deadline provides time to transition existing business relationships; it should not be interpreted as blanket authorization to conduct otherwise prohibited transactions before that date.
Businesses should retain purchase records, inventory documentation, and evidence of their trading partners' DEA registration or timely-applicant status.
However, this does not authorize new purchases from unauthorized businesses. DEA expects timely applicants to verify their trading partners and establish compliant supply chains by November 29, 2026.
Businesses should retain purchase records, inventory documentation, and evidence of their suppliers' DEA registration or timely-applicant status.
-
Pending-application authority is not permanent. A denial or other adverse determination may affect the business's ability to continue operating. Businesses should promptly review any DEA notice and applicable response deadlines.
-
No. Federal registration does not replace existing state licensing, tracking, testing, packaging, transportation, or recordkeeping obligations.
-
Confirm that your DEA submission was timely, retain your confirmation and DCN, and ensure that the registration activities you applied for match what your business actually does.
For growers and processors selling directly to dispensaries, the potential need for separate distributor registration is particularly important. Businesses should review their existing DEA submissions, confirm which activities are covered, and evaluate whether additional registration is necessary. Before transferring products, verify the federal and state authorization of each trading partner.
Legal Disclaimer
This publication is provided for general informational purposes only and reflects our firm's interpretation of applicable federal regulations and DEA guidance as of November 5, 2026.
Certain regulatory provisions remain subject to differing legal interpretations, particularly the relationship between the general coincident-distribution authority under 21 C.F.R. § 1301.13(e)(1) and the marijuana-specific registration provisions under § 1301.13(k)(1). Our interpretation favors separate distributor registration as a conservative compliance approach for manufacturers selling directly to dispensaries. However, this interpretation has not been definitively confirmed through published DEA guidance and should not be construed as an official statement of DEA policy or an established legal requirement.
Federal registration obligations depend on the specific activities and circumstances of each business. This publication does not constitute individualized legal advice, establish an attorney-client relationship, or guarantee any particular regulatory or enforcement outcome. Applicable laws, regulations, and agency guidance remain subject to change.
